| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.0093 | 1 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.0072 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |